APOE and Alzheimer disease: For example, a recently postmenopausal woman with a strong family history of AD, APOE-ε4 positivity, and minimal vascular burden may derive benefit from early transdermal estradiol, particularly if initiated within 5 years of menopause (Kantarci et al., 2016).